Literature DB >> 29181766

Reply to: metoprolol, or propranolol, or carvedilol, or labetalol, for patients with takotsubo syndrome?

Shams Y-Hassan1, Per Tornvall2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29181766     DOI： 10.1007/s10286-017-0483-x

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  5 in total

1.  Plasma catecholamine levels in patients with takotsubo syndrome: Implications for the pathogenesis of the disease.

Authors:  Shams Y-Hassan; Loghman Henareh
Journal:  Int J Cardiol       Date:  2014-11-26       Impact factor: 4.164

2.  Metoprolol, propranolol, carvedilol, or labetalol for patients with Takotsubo syndrome?

Authors:  John E Madias
Journal:  Clin Auton Res       Date:  2017-11-06       Impact factor: 4.435

3.  (123)I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy.

Authors:  Thomas Emil Christensen; Lia Evi Bang; Lene Holmvang; Dorthe Charlotte Skovgaard; Ditte Bang Oturai; Helle Søholm; Jakob Hartvig Thomsen; Hedvig Bille Andersson; Adam Ali Ghotbi; Nikolaj Ihlemann; Andreas Kjaer; Philip Hasbak
Journal:  JACC Cardiovasc Imaging       Date:  2016-06-22

4.  Simultaneous noninvasive recording of skin sympathetic nerve activity and electrocardiogram.

Authors:  Anisiia Doytchinova; Jonathan L Hassel; Yuan Yuan; Hongbo Lin; Dechun Yin; David Adams; Susan Straka; Keith Wright; Kimberly Smith; David Wagner; Changyu Shen; Vicenta Salanova; Chad Meshberger; Lan S Chen; John C Kincaid; Arthur C Coffey; Gang Wu; Yan Li; Richard J Kovacs; Thomas H Everett; Ronald Victor; Yong-Mei Cha; Shien-Fong Lin; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2016-09-23       Impact factor: 6.343

Review 5.  Epidemiology, pathogenesis, and management of takotsubo syndrome.

Authors:  Shams Y-Hassan; Per Tornvall
Journal:  Clin Auton Res       Date:  2017-09-15       Impact factor: 4.435
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.